Homocysteine Is a Risk Factor in Predialysis Patients When Associated with Malnutrition and Inflammation

Table 3

Comparison of the different groups regarding clinical and biochemical parameters.

	Group I	Group II	Group III	Group IV	P-value
	tHcy <25.7 𝜇mol/L,	tHcy <25.7 𝜇mol/L,	tHcy >25.7 𝜇mol/L,	tHcy >25.7 𝜇mol/L,
	mSGA <12.2	mSGNA >12.2	mSGNA <12.2	mSGNA >12.2
Female/male	13/16	10/8	11/17	7/13	.599
Haemoglobin (g/dl)	11.8 ± 1.5	11.7 ± 1.4	11.4 ± 1.7	11.6 ± 1.9	.827
eGFR (ml/min/1.73 m^2)	18.8 ± 7.1	16.4 ± 6.8	16.0 ± 7.1	12.2 ± 5.4	.014
Albumin (g/dL)	4.3 ± 0.4	4.0 ± 0.5	4.3 ± 0.5	4.1 ± 0.4	.032
Hcy (𝜇mol/L)	16.5 ± 3.3	14,9 ± 4.4	32.3 ± 7.1	39.4 ± 9.0	.0001
mSGA	10 ± 1.8	15.4 ± 3.3	9.8 ± 1.6	15.9 ± 2.7	.0001
IL-6 (pg/ml)	3.3 ± 1.8	5.3 ± 3.4	5.3 ± 3.6	8.9 ± 9.3	.03
hs-CRP (mg/dl)	0.45 ± 0.6	1.3 ± 2.2	1.5 ± 2.8	2.2 ± 3.8	.122
TNF-𝛼 (pg/ml)	8.5 ± 3.3	11.6 ± 6.1	12.3 ± 6.3	15.1 ± 14.3	.045